8 results

• Amiodarone Lawsuit MDL Rejected As Claims of Toxicity Continue To Be Filed

  June 3, 2016

  Austin Kirk

  The JPML has rejected a call for the creation of a generic amiodarone MDL, even as more cases are filed, saying there are too few claims and too many defendants to make consolidation efficient for the claims of toxicity, lung damage, and neurological side effects.

• Federal Consolidation Sought For Amiodarone Toxicity Lung Damage Lawsuits

  March 8, 2016

  Irvin Jackson

  A petition has been filed before a panel of federal judges to consolidate all amiordarone toxicity lawsuits before one federal judge for pretrial proceedings.

• Multaq Linked To Increased Risk of Injury In Heart Patients: Study

  April 9, 2015

  Irvin Jackson

  A new study indicates that patients taking the heart drug Multaq are more likely to become hospitalized than patients taking similar heart drugs.

• Nexterone Side Effects May Increase Cancer Risk: Study

  April 9, 2013

  Irvin Jackson

  Taiwan researchers say that side effects of Nexterone (amiodarone) may increase the risk of cancer, particularly among men and those...

• FDA Reverses Limits on Zocor Use in Combination with Amiodarone

  December 16, 2011

  Staff Writers

  Federal drug regulators are reversing themselves on the maximum dose limits placed on the cholesterol drug Zocor when it is...

• Rhabdomyolysis Lawsuit

  June 1, 2011

  AboutLawsuits

  A number of different prescription medications have been linked to an increased risk of the serious and potentially fatal muscle...

• Zocor Rhabdomyolysis Muscle Injury Warning Issued by FDA

  March 22, 2010

  Staff Writers

  High doses of the cholesterol-fighting drug Zocor can increase the risk of rhabdomyolysis, a serious and potentially fatal muscle disease,...

• Rhabdomyolysis Warning Issued by FDA

  August 11, 2008

  AboutLawsuits

  The FDA issued an alert on Friday to remind doctors and the public about the risk of rhabdomyolysis, a rare...